This paper considers top income taxation when (i) new ideas drive economic growth,(ii) the
reward for successful innovation is a top income, and (iii) innovation cannot be perfectly …

Many regulatory agency employees are hired by the firms they regulate, creating a
“revolving door” between government and the private sector. We study these transitions …

While there is relatively limited disagreement on the general need for supporting the
deployment of renewable energy sources for electricity generation (RES-E), there are …

We review the literature on financial intermediation in the process by which new medical
therapeutics are financed, developed, and delivered. We discuss the contributing factors that …

Despite the increased attention for the financialization issue in the academic field, the extent
literature offers limited knowledge about its potential consequence on the innovation …

After a recent increase in Chinese import competition, European firms increased innovation.
We present and rationalise these patterns using 'trapped factors' at the micro level within a …

Pharmaceutical companies often replace prescription drugs that are already on the market
with modified versions that have the same active pharmaceutical ingredient. On the surface …

Vaccines play a crucial role in improving global public health, with the ability to stem the
spread of infectious diseases and the potential to eradicate them completely. Compared with …

We examine how persistent firms' participation is in R&D subsidy and tax incentive
programs, and whether persistence is driven by individual heterogeneity—observed and …

Scholars and policymakers across the ideological spectrum agree that the US drug pricing
system is deeply flawed. Most reform proposals focus on one symptom: high prices for …